CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 16 filers reported holding CLEVELAND BIOLABS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $536,000 | -21.8% | 98,051 | -24.9% | 0.00% | 0.0% |
| Q1 2021 | $685,000 | +20.0% | 130,551 | -21.2% | 0.00% | 0.0% |
| Q4 2020 | $571,000 | +40.3% | 165,651 | -19.9% | 0.00% | – |
| Q3 2020 | $407,000 | -42.0% | 206,751 | -24.3% | 0.00% | -100.0% |
| Q2 2020 | $702,000 | +46.2% | 273,251 | -5.6% | 0.00% | – |
| Q1 2020 | $480,000 | +156.7% | 289,351 | -6.8% | 0.00% | – |
| Q4 2019 | $187,000 | -39.7% | 310,516 | +1.1% | 0.00% | – |
| Q3 2019 | $310,000 | -29.5% | 307,016 | +1.2% | 0.00% | – |
| Q2 2019 | $440,000 | -10.8% | 303,316 | +3.4% | 0.00% | – |
| Q1 2019 | $493,000 | +70.0% | 293,416 | +2.1% | 0.00% | – |
| Q4 2018 | $290,000 | -48.9% | 287,316 | +1.9% | 0.00% | -100.0% |
| Q3 2018 | $567,000 | -61.1% | 281,916 | -46.7% | 0.00% | 0.0% |
| Q2 2018 | $1,459,000 | +83.1% | 528,732 | +103.7% | 0.00% | 0.0% |
| Q1 2018 | $797,000 | -17.5% | 259,616 | +7.7% | 0.00% | 0.0% |
| Q4 2017 | $966,000 | +29.3% | 241,016 | +11.1% | 0.00% | 0.0% |
| Q3 2017 | $747,000 | +31.3% | 217,016 | +12.6% | 0.00% | 0.0% |
| Q2 2017 | $569,000 | +916.1% | 192,716 | +450.4% | 0.00% | – |
| Q1 2017 | $56,000 | +229.4% | 35,016 | +193.9% | 0.00% | – |
| Q4 2016 | $17,000 | -76.1% | 11,916 | -26.7% | 0.00% | – |
| Q2 2015 | $71,000 | -58.7% | 16,266 | -66.3% | 0.00% | – |
| Q1 2015 | $172,000 | – | 48,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|